Related Experiment Video
Updated: Jul 18, 2025

10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
Neurocognitive Dysfunction After Treatment for Pediatric Brain Tumors: Subtype-Specific Findings and Proposal for
Charlotte Sleurs1,2, Paul Fletcher3,4, Conor Mallucci5
1Department of Cognitive Neuropsychology, Tilburg University, 5037 AB, Tilburg, The Netherlands. c.sleurs@tilburguniversity.edu.
Neuroscience Bulletin
|August 24, 2023
Summary
Pediatric brain tumor survivors need neurocognitive assessments informed by neuroscience. This review explores brain connectomes and proposes a framework for tailored follow-up care and rehabilitation.
Area of Science:
- Neuroscience
- Oncology
- Cognitive Science
Background:
- Pediatric brain tumor survivors require integrated oncological and neurocognitive care.
- Tumors and treatments can cause complex neural damage, impacting long-term outcomes.
- Growing research necessitates updated guidance for patient follow-up.
Purpose of the Study:
- To review the role of brain connectomes in neuropsychological outcomes for pediatric brain tumor patients.
- To propose a neuroscientific framework for clinical follow-up and rehabilitation.
Main Methods:
- Review of structural and functional brain connectome literature.
- Analysis of neuropsychological outcomes in relation to tumor type and treatment.
- Development of a theoretical neuroscientific framework.
Main Results:
- Brain connectomes are crucial for understanding neurocognitive deficits in pediatric brain tumor survivors.
- Specific tumor types and treatments correlate with distinct patterns of neural damage and cognitive impairment.
- A framework for personalized follow-up and rehabilitation is proposed.
Conclusions:
- Integrating cognitive neuroscience into pediatric brain tumor care is essential.
- Brain connectome analysis offers a pathway to personalized neurocognitive assessment and intervention.
- The proposed framework can guide future clinical practice and research in rehabilitation trials.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
